You searched for Antibody candidate - Page 66 of 69

In Depth 6 Mar 2023

The biggest private biotech investments in February 2023

…will be used to finance an ongoing phase 1/2 trial of a bispecific antibody treatment for the rare bleeding condition Glanzmann thrombasthenia in addition to the launch of a phase…

March 6, 2023 - 4 minutesmins - By Jonathan Smith

News and Trends 16 Nov 2020

Innate Immunity in Cancer Gains Recognition with Affimed’s €1.8B Deal

…deal’s terms, Affimed will receive €51M upfront to license to Roivant a preclinical-stage antibody drug for several undisclosed types of cancer. Roivant will handle the program once Affimed completes preclinical…

November 16, 2020 - 3 minutesmins - By Jonathan Smith

ethris mrna therapy respiratory infection

News and Trends 1 Feb 2022

Ethris Raises €23M to Make Inhaled Respiratory Therapies from mRNA

…Series B round to fund the development of its lead candidate mRNA therapies — one for respiratory viral infections and the other for the genetic lung condition primary ciliary dyskinesia….

February 1, 2022 - 3 minutesmins - By Jonathan Smith

In Depth 26 May 2023

Could new Lyme disease tests help to prevent chronic infection?

…order to create a better Lyme disease test. Dr Abdo Alnabulsi, chief executive officer (CEO) of EpitogenX, stated: “We are working on a serology based antibody test for the detection…

May 26, 2023 - 10 minutesmins - By Willow Shah-Neville

migraine biotech cgrps heptares review neurology

News and Trends 17 Mar 2016

A Relief for Migraines at last? The Biotech race for the Ultimate Cure

…are in the race for approval of the first migraine antibody drug. These include Teva (Israel) with the drug called TEV-48125 as well the US based Amgen, Eli Lilly and…

March 17, 2016 - 4 minutesmins - By Ekaterina Perets

News and Trends 21 Feb 2018

FDA Approves AstraZeneca’s Lung Cancer Treatment after Rejecting Merck and Pfizer’s

…type of monoclonal antibody known as a checkpoint inhibitor that targets the immune regulatory molecule PD-L1. The FDA approval for Imfinzi is the first authorization of a treatment for lung…

February 21, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 12 Jun 2017

BioNTech Publishes First Data on mRNA-Encoded Cancer Antibodies

BioNTech has reported a new technology that could overcome some of the most challenging issues of antibody production by encoding them into mRNA drugs. BioNTech, one of the most advanced…

June 12, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

Interview 8 Oct 2019

Biotech Hubs: A Tale of Two Cities

…founded the online antibody provider Abcam in 1998. Under his leadership, the company grew to be worth over €2B today. Having met with success, Milner became an angel investor in…

October 8, 2019 - 6 minutesmins - By Jonathan Smith

News and Trends 18 May 2017

Spanish Biotech Clears €2.7M Funding Round for its New Stroke Drug

…comes in addition to Biogen’s Phase II antibody Natalizumab that blocks the recruitment of inflammatory cells. Similar to AptaTarget, French Acticor Biotech just raised €1.5M for its humanized antibody fragment…

May 18, 2017 - 2 minutesmins - By Melanie De Almeida

Impacting vaccine development: COVID-19 and its implications for the future of vaccines

…the vaccination route and frequency, thus impacting the design of the immunization program. The breakthrough COVID-19 vaccines underwent the same checks and balances, with antibody detection methods of ELISA and…

November 3, 2022 - 8 minutesmins - By Sudha Sundaram

News and Trends 1 Nov 2018

Llama Antibodies Could Be the Key to Universal Flu Prevention

…or different targets.” Indeed, the antibody developed by the group was built using four different llama antibodies, two targeting influenza A viruses and two targeting influenza B viruses to cover…

November 1, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 25 Apr 2017

Novartis Negotiates its Way into the US Migraine Market

…drug candidates directed at Alzheimer’s and migraine, under which Amgen received the rights for the U.S., Canada, and Japan, while Novartis was left in charge of the residual markets. Now,…

April 25, 2017 - 2 minutesmins - By Melanie De Almeida

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Antibody candidate

The biggest private biotech investments in February 2023

Innate Immunity in Cancer Gains Recognition with Affimed’s €1.8B Deal

Ethris Raises €23M to Make Inhaled Respiratory Therapies from mRNA

Could new Lyme disease tests help to prevent chronic infection?

A Relief for Migraines at last? The Biotech race for the Ultimate Cure

FDA Approves AstraZeneca’s Lung Cancer Treatment after Rejecting Merck and Pfizer’s

BioNTech Publishes First Data on mRNA-Encoded Cancer Antibodies

Biotech Hubs: A Tale of Two Cities

Spanish Biotech Clears €2.7M Funding Round for its New Stroke Drug

Impacting vaccine development: COVID-19 and its implications for the future of vaccines

Llama Antibodies Could Be the Key to Universal Flu Prevention

Novartis Negotiates its Way into the US Migraine Market

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!